[Code of Federal Regulations] |
[Title 21, Volume 6] |
[CITE: 21CFR516.117] |
|
|
|
CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES |
|
SUBCHAPTER E - ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS |
|
PART 516 -- NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
Subpart C - Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
Sec. 516.117 Submission of correspondence under this subpart.
|
Unless directed otherwise by FDA, all correspondence relating to any aspect of the new animal drug indexing process described in this subpart must be addressed to the Director, OMUMS. The initial correspondence for a particular index listing should include the name and address of the authorized contact person. Notifications of changes in such person or changes of address of such person should be provided in a timely manner.
|
|